A survey of cost, access and outcomes for cannabinoid-based medicinal product use by Australians with endometriosis

Andrew Proudfoot, Sarah Duffy, Justin Sinclair, Jason Abbott, Mike Armour

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

People with endometriosis use cannabis to manage their symptoms. This study aimed to identify costs, modes of administration, product composition, and self- reported effectiveness for those accessing medicinal cannabis in Australia. There were 192 survey responses analysed. Most (63.5%) used a ‘cannabis clinic’ doctor, incurring an initial consultation cost of $100–$200+ (10.2% Medicare bulk- billed) and median cannabinoid medicine costs of $300AUD per month. Cost was a major barrier to access, necessitating reducing dosage (76.1%) and/or consuming illicit cannabis (42.9%), despite a prescription. Most (77%) medical consumers used two or more cannabis products, with delta- 9- tetrahydrocannabinol predominant oil and flower products most frequently prescribed.
Original languageEnglish
Pages (from-to)411-415
Number of pages5
JournalAustralian and New Zealand Journal of Obstetrics and Gynaecology
Volume64
Issue number4
DOIs
Publication statusPublished - Aug 2024

Bibliographical note

Publisher Copyright:
© 2024 The Authors. Australian and New Zealand Journal of Obstetrics and Gynaecology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Open Access - Access Right Statement

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.© 2024 The Authors. Australian and New Zealand Journal of Obstetrics and Gynaecology published by John Wiley & Sons Australia, Ltd on behalf of Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Notes

WIP in RD

Keywords

  • administration method
  • cannabis
  • CBMP
  • chronic pain
  • dose
  • endometriosis
  • insurance

Fingerprint

Dive into the research topics of 'A survey of cost, access and outcomes for cannabinoid-based medicinal product use by Australians with endometriosis'. Together they form a unique fingerprint.

Cite this